Comparison of CTG and T-PRF on Peri-Implant Soft Tissue
Peri-implant Mucositis, Peri-Implantitis, Thin Gingiva
About this trial
This is an interventional treatment trial for Peri-implant Mucositis focused on measuring clinical research, Implant, Implantology, Prospective, Randomized controlled trial, Soft Tissue Grafting, Single-Tooth Implants
Eligibility Criteria
Inclusion Criteria:
- patients older than 18 years,
- thin gingiva biotype,
- one missing tooth in the incisor, canine and premolar area and presence of two natural adjacent teeth
- no bone increasing procedures prior to and during dental implant,
Exclusion Criteria:
- history of a bleeding disorder or on anticoagulant therapy,
- immunocompromised state and debilitating disease,
- smoking and alcoholism,
- poor oral hygiene,
- diabetes.
Sites / Locations
- Bolu Abant Izzet Baysal University
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Thickened with T-PRF
Thickened with CTG
Following local anaesthesia, the measurement of soft tissue thickness at three points [1) occlusal part of the alveolar crest (OAC), 2) midbuccal mucosa level (MBML), 3) over 1 mm of mucogingival junction (MGJ1)] was performed with an endodontic spreader and digital caliber. Following the mid-crestal incision, the buccal flap was raised with double layer technique, while the lingual flap was left to enable direct visibility. The implant bed was drilled according to the manufacturer's protocol. The implants (BEGO Semados® RS/RSX implant system, Bremen, Germany) were placed at the bony crest. Right after the implant placement, the randomisation procedure was performed. In this group, the implants were placed in thin tissues, and T-PRF was inserted in the prepared mucoperiosteal flap at the facial site and secured with horizontal mattresses.
Following local anaesthesia, the measurement of soft tissue thickness at three points [1) occlusal part of the alveolar crest (OAC), 2) midbuccal mucosa level (MBML), 3) over 1 mm of mucogingival junction (MGJ1)] was performed with an endodontic spreader and digital caliber. Following the mid-crestal incision, the buccal flap was raised with double layer technique, while the lingual flap was left to enable direct visibility. The implant bed was drilled according to the manufacturer's protocol. The implants (BEGO Semados® RS/RSX implant system, Bremen, Germany) were placed at the bony crest. Right after the implant placement, the randomisation procedure was performed. In this group, the implants were placed in thin tissues, and CTG was inserted in the prepared mucoperiosteal flap at the facial site and secured with horizontal mattresses.